Kos Biotechnology Partners, a global life sciences investment firm, has made its first investment, to Epikast, a US-Greek consultancy advising pharmaceuticals and other biomedical companies on expanding market access.
AMWAJ Real Estate
Kos Biotechnology Partners, a global life sciences investment firm, has made its first investment, to Epikast, a US-Greek consultancy advising pharmaceuticals and other biomedical companies on expanding market access.